Riverbend Wealth Management
ABBV icon

Riverbend Wealth Management’s AbbVie ABBV Stock Holding History

Riverbend Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.37M Sell
5,247
-150
-3% -$38.5K 0.62% 48
2026
Q2 		$1.36M Buy
5,397
+1,544
+40% +$332K 0.68% 43
2026
Q1 		$838K Buy
3,853
+276
+8% +$61.2K 0.48% 59
2025
Q4 		$817K Buy
3,577
+227
+7% +$51.7K 0.51% 55
2025
Q3 		$776K Buy
3,350
+41
+1% +$8.35K 0.54% 50
2025
Q2 		$614K Buy
3,309
+245
+8% +$45.5K 0.47% 60
2025
Q1 		$642K Buy
3,064
+66
+2% +$12.8K 0.57% 49
2024
Q4 		$534K Buy
+2,998
New +$551K 0.48% 56

Other funds holding ABBV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return

Riverbend Wealth Management's ABBV Position: Q3 2026 in Review

Riverbend Wealth Management reduced its AbbVie (ABBV) stake by 2.8% in Q3 2026, selling an estimated $38.5K and leaving 5,247 shares worth $1.37M. The position accounts for 0.62% of the portfolio, ranked #48.

Riverbend Wealth Management first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. 3,064 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Riverbend Wealth Management held 5,247 shares of AbbVie worth $1.37M as of Q3 2026.
  • Riverbend Wealth Management sold 150 AbbVie shares in Q3 2026, an estimated $38.5K.
  • AbbVie made up 0.62% of Riverbend Wealth Management's portfolio in Q3 2026, its #48 holding.
  • Riverbend Wealth Management first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
  • 3,064 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Riverbend Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.